Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Lung Cancer
Location: United States, ND
Clinical Trial Details
Research Study Summary
Advanced Stage Non-small Cell Lung Cancer
Study to evaluate the long-term safety and efficacy of Darbepoetin Alfa in anemic subjects with Advanced Stage Non-small Cell Lung Cancer receiving multi-cycle chemotherapy.
Patient Inclusion Criteria:
- Subjects with metastatic (stage IV) Non-small Cell Lung cancer, receiving or about receive first line cyclic chemotherapy, life expectancy >6 months, 18 years and older
Patient Exclusion Criteria:
- Subjects with a history of brain metastasis, known primary benign or malignant hematologic disorder which can cause anemia, history of or current, active cancer (other than non-small lung), uncontrolled angina, uncontrolled heart failure or uncontrolled chronic cardiac arrhythmia, subject with history of a seizure disorder.
To Learn more
Both Male and Female
Date Last Changed:
July 24, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.